Preparatory Work to Assess Adherence to Oral Chemotherapy
NCT02895542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86
Last updated 2018-06-08
Summary
This study to find out more about how patients take their anticancer medications and challenges related to taking cancer medications.
Conditions
- Chronic Myeloid Leukemia
Sponsors & Collaborators
-
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Kathryn Weaver, PhD · Wake Forest University Health Sciences
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-20
- Primary Completion
- 2017-04-28
- Completion
- 2017-04-28
Countries
- United States
Study Locations
More Related Trials
-
Trial of Oral Lenalidomide Stewardship Program for Veterans
NCT04835220 ·Status: UNKNOWN ·Phase: NA
-
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
NCT03987555 ·Status: SUSPENDED
-
A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma
NCT02210182 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study to Assess Adherence Oral Anticancer Therapies
NCT03195972 ·Status: COMPLETED
-
A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy
NCT05359848 ·Status: RECRUITING ·Phase: NA
-
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
NCT05123001 ·Status: COMPLETED
-
Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia
NCT00003005 ·Status: COMPLETED ·Phase: PHASE1
-
Pre and Post Treatment Metabolomic Analysis of Leukemia: A Translational Clinical Trial of the Brown Cancer Center
NCT02193100 ·Status: WITHDRAWN
-
Collaborative Network to Take Responsibility for Oral Anticancer Therapy
NCT02861209 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Organoleptic Perception of Oral Nutritional Supplements for Oncological Patients
NCT05488184 ·Status: COMPLETED ·Phase: NA
-
Livertoxcicity in Acute Leukemia Patients During Chemotherapy Treatment
NCT06383325 ·Status: NOT_YET_RECRUITING
-
Pharmacogenomic Testing to Personalize Supportive Oncology
NCT04500301 ·Status: COMPLETED ·Phase: NA
-
Assess the Oral Bioavailability of New ABT-263 Formulations
NCT00743028 ·Status: COMPLETED ·Phase: PHASE1
-
Collaborative Network to Take Responsibility for Oral Anticancer Therapy 2
NCT04142463 ·Status: UNKNOWN ·Phase: NA
-
A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated
NCT00233506 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing
NCT00381173 ·Status: COMPLETED ·Phase: PHASE1
-
Adherence to Oral Anticancer Treatment Using Electronic Monitoring System
NCT01058044 ·Status: COMPLETED ·Phase: NA
-
A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced Cancer
NCT00535522 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Standardized Nutrient Management on Clinical Outcomes of Hematopoientic Stem Cell Transportation Patients
NCT04591340 ·Status: UNKNOWN
-
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
NCT04862585 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
NCT00709215 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Onco-haematology Vigilance Card
NCT04931329 ·Status: UNKNOWN
-
The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors
NCT02522988 ·Status: COMPLETED ·Phase: NA
-
Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics
NCT04091711 ·Status: SUSPENDED ·Phase: NA
-
Short-Term Fasting Before Chemotherapy in Treating Patients With Cancer
NCT01175837 ·Status: COMPLETED ·Phase: NA